Berubicin | MedChemExpress (MCE)
Berubicin (RTA 744 free base; WP 744) is a 4′-O-benzyldoxorubicin that inhibits P-gp and MRP1-mediated efflux and has anticancer activity. Berubicin inhibits glioblastoma multiforme (GBM) and exhibits cytotoxicity. Berubicin has poor bioavailability in mice[1].
| Trivial name | Berubicin |
| Catalog Number | HY-14942 |
| Alternative Name(s) | RTA 744 free base; WP 744 free base; WP 769 |
| Research Area | Cancer |
| CAS# | 677017-23-1 |
| Purity | ≥98.0% |
| SMILES | OC1=C2C([C@@]([H])(O[C@H]3C[C@H](N)[C@H](OCC4=CC=CC=C4)[C@H](C)O3)C[C@@](C(CO)=O)(O)C2)=C(O)C5=C1C(C6=CC=CC(OC)=C6C5=O)=O |
| Size | 5 mg |
| Supplier Page | https://www.medchemexpress.com/berubicin.html |